US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

295.76

-35.4700-10.71%

Post-market: 295.760.00000.00%19:55 EDT

Volume:530.48K

Turnover:162.52M

Market Cap:583.97M

PE:- -

High:323.00

Open:322.79

Low:294.70

Close:331.23

52wk High:341.93

52wk Low:68.00

Shares:1.97M

Float Shares:1.97M

Volume Ratio:1.45

T/O Rate:26.87%

Dividend:1.03

Dividend Rate:0.35%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Jazz Pharmaceuticals (JAZZ) Could Be 13% Undervalued On FDA Approval Of Ziihera

Simply Wall St.

Alignment Healthcare (ALHC), What Is Driving The Fresh Attention?

Simply Wall St.

Why Protagonist Therapeutics (PTGX) Is Down 6.5% After FDA Approval Triggers $275M Milestone Payment

Simply Wall St.

Bajaj Healthcare Dispatches 33rd AGM Notice and FY26 Annual Report

Analysts Are Bullish on Top Healthcare Stocks: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990), Innovent Biologics (IVBXF)

Urumqi Allows Flexible Employment Workers to Access Maternity Insurance Starting September

Ramsay Health Care Limited (ASX:RHC) Pays A AU$0.485 Dividend In Just Three Days

Simply Wall St.

Omega Healthcare Investors (OHI) Stock Still Looks Below Fair Value Despite 102% Returns

Simply Wall St.

Rici Healthcare Holdings (SEHK:1526) Stock Caught Between Low P E And Softer Profit

Simply Wall St.

Schwab US Dividend Equity ETF Sees Inflows Amid Healthcare Developments

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)

What AMN Healthcare Services (AMN)'s New Nursing Leadership Council Role Means For Shareholders

Simply Wall St.

Aster DM Quality Care to Merge Hospitality Subsidiaries for Structural, Operational Gains

Neurocrine Biosciences (NBIX) Cleared An FDA Milestone, Is It Trading At A Discount?

Simply Wall St.

National Healthcare Insider Makes Major Move in High-Value Stock Sale

Insider Move: Sensus Healthcare Director Quietly Boosts His Stake in the Company

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda's Mimrylo Gets FDA Approval to Treat Blood Cancer Condition

Takeda receives FDA approval of NDA for Mimrylo

FDA Authorizes Juul to Sell New E-Cigarette

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.etasphere.com/stock/LABU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":295.76,"timestamp":1787947200000,"preClose":331.23,"halted":0,"volume":530479,"hourTrading":{"tag":"盘后","latestPrice":295.76,"preClose":295.76,"latestTime":"19:55 EDT","volume":2719,"amount":805526.7898,"timestamp":1787961358839,"change":0,"changeRate":0,"amplitude":0.003466},"delay":0,"changeRate":-0.10708571083537127,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Market Closed","change":-35.47,"latestTime":"08-28 16:00:00 EDT","open":322.785,"high":323,"low":294.7,"amount":162523074.03118002,"amplitude":0.085439,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":331.23,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.003472,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":323.7,"preClose":331.23,"latestTime":"09:29 EDT","volume":2163,"amount":708605.00781,"timestamp":1787923795309,"change":-7.53,"changeRate":-0.022733,"amplitude":0.034055},"postHourTrading":{"tag":"盘后","latestPrice":295.76,"preClose":295.76,"latestTime":"19:55 EDT","volume":2719,"amount":805526.7898,"timestamp":1787961358839,"change":0,"changeRate":0,"amplitude":0.003466},"volumeRatio":1.445542973311124,"impliedVol":0.9101,"impliedVolPercentile":0.5259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.445542973311124,"shares":1974486,"dividePrice":1.0268,"high":323,"amplitude":0.085439,"preClose":331.23,"low":294.7,"week52Low":68,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":295.76,"eps":0,"divideRate":0.003472,"volume":530479,"delay":0,"ttmEps":0,"open":322.785,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":317.2,"twentyDayClose":227.4,"sixtyDayClose":165.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663819042","title":"Jazz Pharmaceuticals (JAZZ) Could Be 13% Undervalued On FDA Approval Of Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2663819042","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663819042?lang=en_us&edition=fundamental","pubTime":"2026-08-30 23:22","pubTimestamp":1788103340,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals (JAZZ) is in focus after the FDA approved Ziihera-based regimens for first-line treatment of adults with unresectable locally advanced or metastatic HER2-positive gastroesophageal adenocarcinoma, supported by Phase 3 HERIZON GEA 01 data.\nJazz Pharmaceuticals’ recent FDA decision arrives after a strong run in the stock, with the share price up 41.23% year to date and a 1-year total shareholder return of 91.42%. This comes even though the 7-day share price return declined...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/jazz-pharmaceuticals-jazz-could-be-13-undervalued-on-fda-app","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/jazz-pharmaceuticals-jazz-could-be-13-undervalued-on-fda-app","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0320765992.SGD","BK4585","IE00BN0W2W23.USD","BK4007","LABU","LU0889565916.HKD","LU0109394709.USD","JAZZ","BK4532","BK4533","LU0154245673.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4588","LU0154245756.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663448740","title":"Alignment Healthcare (ALHC), What Is Driving The Fresh Attention?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663448740","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663448740?lang=en_us&edition=fundamental","pubTime":"2026-08-30 19:25","pubTimestamp":1788089139,"startTime":"0","endTime":"0","summary":"Why Alignment Healthcare Stock Is Back in Focus\nAlignment Healthcare (ALHC) is under fresh scrutiny after multiple shareholder rights law firms announced investigations into alleged accounting issues flagged by a whistleblower, including claims about misclassified expenses and inflated financial metrics.\nAt a recent share price of US$13.62, Alignment Healthcare has seen short term momentum revive, with a 7 day share price return of 3.5% and a 90 day gain of 2.4%, although the 30 day share...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/alignment-healthcare-alhc-what-is-driving-the-fresh-attentio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/alignment-healthcare-alhc-what-is-driving-the-fresh-attentio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI","XLV","ALHC","BK4588","BK4585","LABU","BK4581","BK4154","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044809","title":"Why Protagonist Therapeutics (PTGX) Is Down 6.5% After FDA Approval Triggers $275M Milestone Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044809","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044809?lang=en_us&edition=fundamental","pubTime":"2026-08-30 19:19","pubTimestamp":1788088791,"startTime":"0","endTime":"0","summary":"Takeda recently announced that the U.S. FDA approved MIMRYLO (rusfertide), a first-in-class hepcidin mimetic peptide, for treating erythrocytosis in adults with polycythemia vera, triggering US$275,000,000 in milestone payments to Protagonist Therapeutics.\nThis approval not only validates Protagonist’s peptide platform but also establishes the first approved hepcidin mimetic therapy in polycythemia vera, potentially reshaping treatment approaches for hematocrit control and phlebotomy...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ptgx/protagonist-therapeutics/news/why-protagonist-therapeutics-ptgx-is-down-65-after-fda-appro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ptgx/protagonist-therapeutics/news/why-protagonist-therapeutics-ptgx-is-down-65-after-fda-appro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","PTGX","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663041656","title":"Bajaj Healthcare Dispatches 33rd AGM Notice and FY26 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2663041656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663041656?lang=en_us&edition=fundamental","pubTime":"2026-08-30 18:02","pubTimestamp":1788084158,"startTime":"0","endTime":"0","summary":"Bajaj Healthcare Ltd ( ($IN:BAJAJHCARE) ) just unveiled an update. Bajaj Healthcare Ltd has announced that it has dispatched the notice for its 33r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bajaj-healthcare-dispatches-33rd-agm-notice-and-fy26-annual-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bajaj-healthcare-dispatches-33rd-agm-notice-and-fy26-annual-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4137","LU0128526141.USD","HCSG","XBI","BK4588","LU0029874061.USD","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663049261","title":"Analysts Are Bullish on Top Healthcare Stocks: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990), Innovent Biologics (IVBXF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663049261","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663049261?lang=en_us&edition=fundamental","pubTime":"2026-08-30 17:01","pubTimestamp":1788080464,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-sichuan-kelun-biotech-biopharmaceutical-co-ltd-class-h-hk6990-innovent-biologics-ivbxf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-sichuan-kelun-biotech-biopharmaceutical-co-ltd-class-h-hk6990-innovent-biologics-ivbxf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","HCSG","BK4137","BK4585","XLV","XBI","LU0128526141.USD","BK4581","IVBXF","LU0029874061.USD","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137999186","title":"Urumqi Allows Flexible Employment Workers to Access Maternity Insurance Starting September","url":"https://stock-news.laohu8.com/highlight/detail?id=1137999186","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137999186?lang=en_us&edition=fundamental","pubTime":"2026-08-30 15:40","pubTimestamp":1788075623,"startTime":"0","endTime":"0","summary":"Authorities in Urumqi have announced that flexible employment workers will soon be eligible for maternity insurance coverage. A recent joint notice from six municipal departments, including the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4585","LABU","BK4581","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663041045","title":"Ramsay Health Care Limited (ASX:RHC) Pays A AU$0.485 Dividend In Just Three Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2663041045","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663041045?lang=en_us&edition=fundamental","pubTime":"2026-08-30 08:45","pubTimestamp":1788050724,"startTime":"0","endTime":"0","summary":"Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-rhc/ramsay-health-care-shares/news/ramsay-health-care-limited-asxrhc-pays-a-au0485-dividend-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-rhc/ramsay-health-care-shares/news/ramsay-health-care-limited-asxrhc-pays-a-au0485-dividend-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VIG","BK4585","BK4588","FEBU","PMDE","VOTE","JOYT","XBI","DECU","BK4581","VGFPF","RGLO","LABU","XLV","BK7113","RHC.AU","GXDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043433","title":"Omega Healthcare Investors (OHI) Stock Still Looks Below Fair Value Despite 102% Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043433","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043433?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:21","pubTimestamp":1788045717,"startTime":"0","endTime":"0","summary":"Omega Healthcare Investors has more than doubled shareholders' money over the past five years, yet several valuation checks still point to the stock trading at a discount to its estimated intrinsic value. With the share price recently at US$45.99 and short term returns under pressure, investors are weighing how much of that long term gain is already reflected in today’s valuation.\n\nOmega Healthcare Investors has returned 101.6% over five years. This puts the recent pullback in context as a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/324452-main-header/1585187590195","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/324452-main-header/1585187590195"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-ohi/omega-healthcare-investors/news/omega-healthcare-investors-ohi-stock-still-looks-below-fair","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-ohi/omega-healthcare-investors/news/omega-healthcare-investors-ohi-stock-still-looks-below-fair","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","TSPA","JOYT","BK4585","SPHQ","PMDE","FEBU","XLV","GXDW","OHI","LABU","BK4225","VGFPF","VOTE","SRET","RGLO","BK4581","BK4203","TACU","CDIG","DCF","XBI","SRHR","DECU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663483820","title":"Rici Healthcare Holdings (SEHK:1526) Stock Caught Between Low P E And Softer Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2663483820","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663483820?lang=en_us&edition=fundamental","pubTime":"2026-08-30 04:36","pubTimestamp":1788035805,"startTime":"0","endTime":"0","summary":"Rici Healthcare Holdings entered this earnings day with a stock that has fallen 21% over the past month, even as trailing earnings support a P/E of just 3.7x against a much higher sector average. The headline from the latest half year is clear: profit growth has cooled sharply, with H1 2026 net income of ¥45.6m and basic earnings per share of ¥0.03.\nThe expectation gap now sits squarely on earnings quality. Margins over the past twelve months remain in double digits; however, the latest half...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1526/rici-healthcare-holdings-shares/news/rici-healthcare-holdings-sehk1526-stock-caught-between-low-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1526/rici-healthcare-holdings-shares/news/rici-healthcare-holdings-sehk1526-stock-caught-between-low-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01526","HCSG","DECU","JOYT","GXDW","FEBU","VGFPF","BK1209","BK4588","PMDE","XBI","BK4581","BK4137","LU0128526141.USD","RGLO","LABU","XLV","BK4585","VOTE","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663715017","title":"Schwab US Dividend Equity ETF Sees Inflows Amid Healthcare Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2663715017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663715017?lang=en_us&edition=fundamental","pubTime":"2026-08-30 00:01","pubTimestamp":1788019278,"startTime":"0","endTime":"0","summary":"Schwab US Dividend Equity ETF ( $SCHD ) has fallen by 0.88% in the past week. It has experienced a 5-day net inflow of $640.6 million. This is due,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/schwab-us-dividend-equity-etf-sees-inflows-amid-healthcare-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/schwab-us-dividend-equity-etf-sees-inflows-amid-healthcare-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","SCHD","BK4137","LU0029874061.USD","BK4581","BK4585","FDN","LU0128526141.USD","BK4215","EQR","XBI","XLV","LABU","HCSG","BK4550","REZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663464017","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663464017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663464017?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:30","pubTimestamp":1788013830,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Spyre Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD","BK4581","IE00BJT1NW94.SGD","BK4585","IE00B2B36J28.USD","BK4588","SYRE","LU0889565916.HKD","XBI","BK4139","BK4137","LABU","IE0009354923.USD","IDNA","PTH","LU0109394709.USD","CANC","XLV","HCSG","LU0128526141.USD","BBH","IE0002141913.USD","IE0009355771.USD","LU0029874061.USD","IE00BJJMRZ35.SGD","LFSC","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017727","title":"What AMN Healthcare Services (AMN)'s New Nursing Leadership Council Role Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017727","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017727?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:20","pubTimestamp":1788013257,"startTime":"0","endTime":"0","summary":"AMN Healthcare Services recently joined the AONL Foundation Corporate Advisory Council, where it will be represented by Chief Nursing Executive Dr. Angelo Venditti and Head of Strategic Enterprise & Channel Partnerships Steven Endsley to support research, innovation and education in nursing leadership nationwide.\nThis council role gives AMN a platform to shape workforce innovation and nursing leadership priorities, aligning its workforce-planning and analytics capabilities with national...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-amn/amn-healthcare-services/news/what-amn-healthcare-services-amns-new-nursing-leadership-cou","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-amn/amn-healthcare-services/news/what-amn-healthcare-services-amns-new-nursing-leadership-cou","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XLV","BK4585","BK4196","LABU","XBI","BK7095","BK4588","AMN.AU","BK4581","AMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017625","title":"Aster DM Quality Care to Merge Hospitality Subsidiaries for Structural, Operational Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017625?lang=en_us&edition=fundamental","pubTime":"2026-08-29 21:12","pubTimestamp":1788009157,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aster DM Healthcare Ltd. ( ($IN:ASTERDM) ). Aster DM Quality Care Limited has announced that the boards of its ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-to-merge-hospitality-subsidiaries-for-structural-operational-gains?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-to-merge-hospitality-subsidiaries-for-structural-operational-gains?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","XBI","BK4588","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017369","title":"Neurocrine Biosciences (NBIX) Cleared An FDA Milestone, Is It Trading At A Discount?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017369","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017369?lang=en_us&edition=fundamental","pubTime":"2026-08-29 17:19","pubTimestamp":1787995165,"startTime":"0","endTime":"0","summary":"FDA milestone puts Neurocrine Biosciences in focus\nThe FDA’s acceptance of Neurocrine Biosciences (NBIX) Investigational New Drug application for NBI-1117567 clears the way for a Phase 2 trial in Alzheimer’s cognition and triggers a US$10 million payment to partner Nxera Pharma.\nDespite the FDA milestone, Neurocrine Biosciences’ recent share price momentum has cooled, with the 30 day share price return down 14.79%, even as the year to date share price return is up 9.57% and the 5 year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/neurocrine-biosciences-nbix-cleared-an-fda-milestone-is-it-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/neurocrine-biosciences-nbix-cleared-an-fda-milestone-is-it-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065170008.USD","LU0154245756.USD","LU2065171402.SGD","LU0109394709.USD","LU0889565916.HKD","LU0154245673.USD","BK4585","LU0320765992.SGD","LU2065169927.USD","LU2065171311.SGD","LABU","BK4139","LU2324357040.USD","CDIG","BK4588","LU0823416689.USD","NBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663011983","title":"National Healthcare Insider Makes Major Move in High-Value Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2663011983","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663011983?lang=en_us&edition=fundamental","pubTime":"2026-08-29 10:10","pubTimestamp":1787969445,"startTime":"0","endTime":"0","summary":"New insider activity at National Healthcare ( ($NHC) ) has taken place on August 28, 2026. Director David R. Gifford has recently sold 1,779 shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/national-healthcare-insider-makes-major-move-in-high-value-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/national-healthcare-insider-makes-major-move-in-high-value-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4581","BK4185","XLV","NHC","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663011614","title":"Insider Move: Sensus Healthcare Director Quietly Boosts His Stake in the Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2663011614","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663011614?lang=en_us&edition=fundamental","pubTime":"2026-08-29 10:10","pubTimestamp":1787969423,"startTime":"0","endTime":"0","summary":"New insider activity at Sensus Healthcare ( ($SRTS) ) has taken place on August 28, 2026. Director Eric Sachetta has increased his stake in Sensus ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-move-sensus-healthcare-director-quietly-boosts-his-stake-in-the-company-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-move-sensus-healthcare-director-quietly-boosts-his-stake-in-the-company-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","SRTS","BK4082","XLV","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PINK","BK4585","MEDI","MRNY","MRNX","NVIB","IDNA","BBP","PSCH","LFSC","TBXU","XLVX","BMED","RSPH","GNMX","TECB","IEIH","SYNB","GDOC","IBB","IYH","FRTY","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016729","title":"Takeda's Mimrylo Gets FDA Approval to Treat Blood Cancer Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016729","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016729?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:02","pubTimestamp":1787958120,"startTime":"0","endTime":"0","summary":"Takeda's treatment for erythrocytosis in adults with polycythemia vera, a form of blood cancer, received approval from the Food and Drug Administration.The company said Friday that the FDA approved its new drug application for Mimrylo, also known as rusfertide. The drug treats adults with erythrocytosis who have PV, a condition involving an abnormally high concentration of red blood cells.\"The approval of Mimrylo underscores the strength of Takeda's late-stage pipeline and our focus on developing genuinely differentiated therapies for patients who are urgently waiting for new options,\" Chief Executive Julie Kim said.The development does not impact Takeda's guidance for the current fiscal year, the company said.The agency's approval was based on data from the company's Phase 3 trial of the treatment. An open-label extension of that trial is continuing, and the company said it is engaging with international regulators about the drug.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","TAK","LABU","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","GDOC","LABU","SYNB","IEIH","LFSC","MEDI","PSCH","BK4007","BK4585","PINK","IBB","TAK","GNMX","BK4588","TECB","NVIB","FRTY","MRNX","IYH","BMED","MRNY","IDNA","XLVX","RSPH","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006015","title":"FDA Authorizes Juul to Sell New E-Cigarette","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006015","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663006015?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:47","pubTimestamp":1787953620,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration gave Juul Labs the go-ahead to sell a new version of its e-cigarette and tobacco- and menthol-flavored pods, marking another win for the company after it got clearance","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":1,"totalSize":398,"code":"91000000","status":"200"}]}}